DaVita Inc $ 120.32 2.22 (1.88%)
Volume:
571,426
Avg Vol (1m):
708,425
Market Cap $:
13.48 Bil
Enterprise Value $:
24.03 Bil
P/E (TTM):
18.06
P/B:
8.70
Current and historical daily P/E ratio for DVA (DaVita Inc) from 1995 to Jan 20 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. DaVita stock (DVA) PE ratio as of Jan 20 2021 is 18.06.
More Details
DaVita PE Ratio (TTM) Chart
EMBED
DaVita PE Ratio (TTM) Historical Data
View and export this data going back to 1995. Start your Free Trial
Total 1254
- 1
- 2
- 3
- 4
- 5
- 6
- 14
DaVita PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2021-01-21 | 18.0 | 2020-11-19 | 16.1 |
2021-01-20 | 18.0 | 2020-11-18 | 16.2 |
2021-01-19 | 17.7 | 2020-11-17 | 17.0 |
2021-01-18 | 17.8 | 2020-11-16 | 17.0 |
2021-01-15 | 17.8 | 2020-11-13 | 16.6 |
2021-01-14 | 17.9 | 2020-11-12 | 16.1 |
2021-01-13 | 18.1 | 2020-11-11 | 15.9 |
2021-01-12 | 18.6 | 2020-11-10 | 16.1 |
2021-01-11 | 18.5 | 2020-11-09 | 15.3 |
2021-01-08 | 18.6 | 2020-11-06 | 14.8 |
2021-01-07 | 18.3 | 2020-11-05 | 14.7 |
2021-01-06 | 18.1 | 2020-11-04 | 14.4 |
2021-01-05 | 17.5 | 2020-11-03 | 13.9 |
2021-01-04 | 17.5 | 2020-11-02 | 13.4 |
2021-01-01 | 17.6 | 2020-10-30 | 12.9 |
2020-12-31 | 17.6 | 2020-10-29 | 12.9 |
2020-12-30 | 17.3 | 2020-10-28 | 12.9 |
2020-12-29 | 17.4 | 2020-10-27 | 13.4 |
2020-12-28 | 17.3 | 2020-10-26 | 13.5 |
2020-12-25 | 17.3 | 2020-10-23 | 13.7 |
2020-12-24 | 17.3 | 2020-10-22 | 13.6 |
2020-12-23 | 17.2 | 2020-10-21 | 13.4 |
2020-12-22 | 17.3 | 2020-10-20 | 13.5 |
2020-12-21 | 17.4 | 2020-10-19 | 13.4 |
2020-12-18 | 17.3 | 2020-10-16 | 13.6 |
2020-12-17 | 17.4 | 2020-10-15 | 13.3 |
2020-12-16 | 17.0 | 2020-10-14 | 13.3 |
2020-12-15 | 16.9 | 2020-10-13 | 13.3 |
2020-12-14 | 16.4 | 2020-10-12 | 13.3 |
2020-12-11 | 16.2 | 2020-10-09 | 13.2 |
2020-12-10 | 16.8 | 2020-10-08 | 13.3 |
2020-12-09 | 16.7 | 2020-10-07 | 13.1 |
2020-12-08 | 16.6 | 2020-10-06 | 12.8 |
2020-12-07 | 16.3 | 2020-10-05 | 13.0 |
2020-12-04 | 16.4 | 2020-10-02 | 12.6 |
2020-12-03 | 15.8 | 2020-10-01 | 12.4 |
2020-12-02 | 16.3 | 2020-09-30 | 12.8 |
2020-12-01 | 16.3 | 2020-09-29 | 12.6 |
2020-11-30 | 16.5 | 2020-09-28 | 12.7 |
2020-11-27 | 16.5 | 2020-09-25 | 13.2 |
2020-11-26 | 16.4 | 2020-09-24 | 12.9 |
2020-11-25 | 16.4 | 2020-09-23 | 13.0 |
2020-11-24 | 16.4 | 2020-09-22 | 13.4 |
2020-11-23 | 16.5 | 2020-09-21 | 13.4 |
2020-11-20 | 16.5 | 2020-09-18 | 13.8 |
DaVita PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Compare
NYSE:UHS
NYSE:CHE
NYSE:EHC
NAS:AMED
NAS:LHCG
NAS:ACHC
NYSE:THC
NAS:OPCH
NAS:ENSG
NYSE:SEM
NYSE:HCA
XTER:FRE
XTER:FME
SZSE:300015
XKLS:5225
BKK:BDMS
ASX:RHC
ASX:SHL
XPAR:ORP
BSP:HAPV3
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates about 3,000 facilities worldwide, mostly in the U.S., and treats over 235,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government ( primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.